Mitochondrial Dysfunction and Increased Reactive Oxygen Species Impair Insulin Secretion in Sphingomyelin Synthase 1-null Mice*

Sphingomyelin synthase 1 (SMS1) catalyzes the conversion of ceramide to sphingomyelin. Here, we generated and analyzed SMS1-null mice. SMS1-null mice exhibited moderate neonatal lethality, reduced body weight, and loss of fat tissues mass, suggesting that they might have metabolic abnormality. Indeed, analysis on glucose metabolism revealed that they showed severe deficiencies in insulin secretion. Isolated mutant islets exhibited severely impaired ability to release insulin, dependent on glucose stimuli. Further analysis indicated that mitochondria in mutant islet cells cannot up-regulate ATP production in response to glucose. We also observed additional mitochondrial abnormalities, such as hyperpolarized membrane potential and increased levels of reactive oxygen species (ROS) in mutant islets. Finally, when SMS1-null mice were treated with the anti-oxidant N-acetyl cysteine, we observed partial recovery of insulin secretion, indicating that ROS overproduction underlies pancreatic β-cell dysfunction in SMS1-null mice. Altogether, our data suggest that SMS1 is important for controlling ROS generation, and that SMS1 is required for normal mitochondrial function and insulin secretion in pancreatic β-cells.

[1]  Ryo Taguchi,et al.  Global analysis of triacylglycerols including oxidized molecular species by reverse-phase high resolution LC/ESI-QTOF MS/MS. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  T. Yamaji,et al.  CERT-mediated trafficking of ceramide. , 2009, Biochimica et biophysica acta.

[3]  R. Wadgaonkar,et al.  Sphingomyelin Synthase 2 Is One of the Determinants for Plasma and Liver Sphingomyelin Levels in Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Acharya,et al.  Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice , 2009, The Journal of cell biology.

[5]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[6]  R. Wadgaonkar,et al.  Sphingomyelin Synthase 2 Deficiency Attenuates NF&kgr;B Activation , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Y. Hannun,et al.  Molecular targeting of acid ceramidase: implications to cancer therapy. , 2008, Current drug targets.

[8]  M. Brand,et al.  On the role of uncoupling protein-2 in pancreatic beta cells. , 2008, Biochimica et biophysica acta.

[9]  A. Tarca,et al.  Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage. , 2008, Experimental cell research.

[10]  R. Schneiter,et al.  Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.

[11]  G. Meer,et al.  Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.

[12]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[13]  T. Gotoh,et al.  In vitro analysis of Bcl-2 proteins in mitochondria and endoplasmic reticulum: similarities in anti-apoptotic functions and differences in regulation. , 2007, Experimental cell research.

[14]  S. Milstien,et al.  Autocrine and paracrine roles of sphingosine-1-phosphate , 2007, Trends in Endocrinology & Metabolism.

[15]  Y. Hannun,et al.  Translational aspects of sphingolipid metabolism. , 2007, Trends in molecular medicine.

[16]  J. Acharya,et al.  Ceramide transfer protein function is essential for normal oxidative stress response and lifespan , 2007, Proceedings of the National Academy of Sciences.

[17]  J. Brenton,et al.  Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. , 2007, Cancer cell.

[18]  F. Goñi,et al.  Sphingolipids and cell death , 2007, Apoptosis.

[19]  M. Cabot,et al.  Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. , 2006, Biochimica et biophysica acta.

[20]  F. Tafesse,et al.  The Multigenic Sphingomyelin Synthase Family* , 2006, Journal of Biological Chemistry.

[21]  A. Wiederkehr,et al.  Minireview: implication of mitochondria in insulin secretion and action. , 2006, Endocrinology.

[22]  J. Hirst,et al.  The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Mimori,et al.  Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis , 2005, The Journal of experimental medicine.

[24]  T. Suda,et al.  Angiopoietin-related growth factor antagonizes obesity and insulin resistance , 2005, Nature Medicine.

[25]  Takao Shimizu,et al.  A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[26]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[27]  Y. Hannun,et al.  The complex life of simple sphingolipids , 2004, EMBO reports.

[28]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[29]  Shohei Yamaoka,et al.  Expression Cloning of a Human cDNA Restoring Sphingomyelin Synthesis and Cell Growth in Sphingomyelin Synthase-defective Lymphoid Cells* , 2004, Journal of Biological Chemistry.

[30]  J. Rabek,et al.  Oxidatively damaged proteins of heart mitochondrial electron transport complexes. , 2004, Biochimica et biophysica acta.

[31]  B. Miroux,et al.  The biology of mitochondrial uncoupling proteins. , 2004, Diabetes.

[32]  Satoshi Yasuda,et al.  Molecular machinery for non-vesicular trafficking of ceramide , 2003, Nature.

[33]  A. Merrill,et al.  Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action. , 2003, Pharmacological research.

[34]  Y. Hannun,et al.  Ceramide in apoptosis: an overview and current perspectives. , 2002, Biochimica et biophysica acta.

[35]  Li Fang,et al.  Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence , 2002, The EMBO journal.

[36]  C. Wollheim,et al.  Mitochondrial function in normal and diabetic β-cells , 2001, Nature.

[37]  Y. Hannun,et al.  Enzymes of sphingolipid metabolism: from modular to integrative signaling. , 2001, Biochemistry.

[38]  M. Mori,et al.  Identification and Functional Analysis of Human Tom22 for Protein Import into Mitochondria , 2000, Molecular and Cellular Biology.

[39]  C. Hoppel,et al.  Direct Inhibition of Mitochondrial Respiratory Chain Complex III by Cell-permeable Ceramide* , 1997, The Journal of Biological Chemistry.

[40]  A. Colell,et al.  Direct Effect of Ceramide on the Mitochondrial Electron Transport Chain Leads to Generation of Reactive Oxygen Species , 1997, The Journal of Biological Chemistry.

[41]  B. Ames,et al.  Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Hannun Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[43]  B. Ames,et al.  Oxidative DNA damage and senescence of human diploid fibroblast cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Hannun,et al.  Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.

[45]  F. Ashcroft,et al.  Insulin secretion from beta-cells is affected by deletion of nicotinamide nucleotide transhydrogenase. , 2009, Methods in enzymology.

[46]  F. Ashcroft,et al.  Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion. , 2006, Cell metabolism.

[47]  Y. Matsuzawa,et al.  Overexpression of Dominant-Negative Mutant Hepatocyte Nuclear Factor-1α in Pancreatic β-Cells Causes Abnormal Islet Architecture With Decreased Expression of E-Cadherin, Reduced β-cell Proliferation, and Diabetes , 2002 .

[48]  P. Meda,et al.  Isolation of pancreatic islets and primary culture of the intact microorgans or of dispersed islet cells. , 1990, Methods in enzymology.